Truffle dog C’s Post

View profile for Truffle dog C, graphic

Hail Mary Narratives / Fan / Supporter

Nice! Will AI driven drug discoveries create a test animal shortage? Imagine if Ken Griffin created a new “project warp speed” for animal testing, because with all the new AI drug discovery right around the corner - it seems likely that there will be a GPU-like test animals shortage that delays progress.. And what if animal testing can be a win-win for the test animals and their human counterparts.. and also fun. Example: Why not breed and clone polar bear sized sled dogs - who will surely have a ton of health problems to solve - but in the meantime they have a great life as they are autonomously trained to sniff out rare earth metals in the arctic (for fun) while also contributing economically. Also, wouldn’t it be best if a cerebral super drug is tested on super intelligent NYC and Chicago rats? Ken’s Kennel (for lack of a better name) can capture and breed rats from the city. Perhaps the rats can even be autonomously trained to do something economical too… Imagine - free range test animals that contribute economically! Just a germ of an idea. Obviously people in Ken's crew would come up with the real insight. My point is that maybe breeding test animals can be fun.. and kind.. and insanely contributive to mankind!

View organization page for Griffin Catalyst, graphic

3,183 followers

This morning, Ken Griffin joined Dr. Selwyn Vickers, Robin Roberts, and Lara Spencer on Good Morning America to announce the largest donation in Memorial Sloan Kettering Cancer Center’s nearly 150-year history. The landmark $400 million gift from Ken Griffin, Founder of Griffin Catalyst, and David Geffen, Founder of the David Geffen Foundation, will advance cancer care, treatment, and outcomes for people in New York City and around the world, helping MSK’s incredible physicians, scientists, and care providers create more hope and possibility for every person with cancer.   Watch the full segment here: https://lnkd.in/gkf6wuxU

To view or add a comment, sign in

Explore topics